Popular, Venture Capital, Pharmaceutical Industry

Will Labour’s policy prescription create a stronger UK life sciences sector?

A&O Shearman on 3/27/2025

The UK government plans to turbocharge the life sciences sector using policy levers to enhance research and development, innovation hubs, and private fundraising. In this piece, Michael Bloch explores how refinements to...more

The Life Sciences Report – June 2024

Wilson Sonsini Goodrich & Rosati on 6/11/2024

This latest edition features articles on biotech client Siolta Therapeutics, the use of safety and efficacy findings to extend drug exclusivity periods, life sciences venture financings for clients in 2023, and updated USPTO...more

Healthcare Experts See Promising Signs of Rebound in M&A and IPO Activity

Goodwin on 2/28/2024

In the second week of January, Goodwin and KPMG convened innovators, practitioners, regulators, and others for our annual symposium on the future of life sciences and healthcare. This marked the fifth year that Goodwin...more

Digital Health Has Strong Fundamentals to Pull Through Downturn

Fenwick & West Life Sciences Group on 9/9/2022

Digital health has been a powerhouse investment sector since it emerged more than a decade ago. Year-after-year, startups consistently demonstrate their innovations bring real-world benefits and our healthcare system...more

Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2021

Orrick, Herrington & Sutcliffe LLP on 7/22/2021

This edition of Orrick’s life sciences publication series reviews the key drivers of venture investment in the life sciences industry, which is proceeding at a record pace thus far in 2021. Key findings include: Investment...more

Global Trends and Opportunities in Life Sciences Real Estate – Spotlighting the U.S. and the UK

Goodwin on 9/30/2020

An aging global population, a once-in-a-century pandemic and the continued convergence of scientific breakthroughs like cell and gene therapies and artificial intelligence are among just a few of the key factors that continue...more

Healthcare Financing Trends

Mayer Brown Free Writings + Perspectives on 8/20/2020

CBInsights recently hosted a webcast, The State of Healthcare Q2 2020. Capital raising by companies in the global healthcare sector yielded a historic high of $18.1 billion in the second quarter of 2020, and deal volume rose...more

Vital Signs: Digital Health Law Update | Summer 2020

Jones Day on 7/21/2020

Note From the Editors - With this Summer 2020 issue of Vital Signs, we take a moment to again applaud the remarkable actions of all the health care and life science organizations around the globe working tirelessly on our...more

Financial Daily Dose 1.31.2020 | Top Story: IBM CEO Ginni Rometty is Out After Eight Years at the Helm

Robins Kaplan LLP on 1/31/2020

In a week that’s already seen plenty of C-suite shakeups, we’ve learned that Ginni Rometty is stepping down from her role as CEO at IBM. The company’s cloud computing chief, Arvind Krishna, will take over for her, though...more

[Event] 3rd Annual Shanghai Life Sciences Forum - November 12th, Shanghai, China

McDermott Will & Schulte on 10/30/2019

MWE China Law Offices and its strategic alliance partner McDermott Will & Emery are proud to co-host our annual Shanghai Life Sciences Forum in partnership with the Redefining Early Stage Investments (RESI) conference. This...more

The Life Sciences Report - Winter/Spring 2019

Wilson Sonsini Goodrich & Rosati on 3/15/2019

Venture Fundraising and Investment in Healthcare - U.S. healthcare venture fundraising reached a record $9.6 billion in 2018, continuing a four-year upward trend. This was driven by excellent returns in the sector,...more

The Life Sciences Report - Winter 2018

Wilson Sonsini Goodrich & Rosati on 1/11/2018

Life Beyond FDA Clearance or Approval: The Reimbursement Challenge - To medical device manufacturers, winning premarket approval or 510(k) clearance from the U.S. Food and Drug Administration (FDA) is only half the battle....more

Today's Popular Updates › Venture Capital › Pharmaceutical Industry

"My best business intelligence, in one easy email…"